Tower Research Capital LLC (TRC) - CYTOMX THERAPEUTICS INC ownership

CYTOMX THERAPEUTICS INC's ticker is CTMX and the CUSIP is 23284F105. A total of 63 filers reported holding CYTOMX THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.10 and the average weighting 0.0%.

Quarter-by-quarter ownership
Tower Research Capital LLC (TRC) ownership history of CYTOMX THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$10,618
-26.0%
8,231
-1.3%
0.00%
Q2 2023$14,350
+20697.1%
8,343
-81.6%
0.00%
-100.0%
Q1 2023$69
+30.2%
45,351
+37.0%
0.00%0.0%
Q4 2022$53
-99.9%
33,103
+28.7%
0.00%
+100.0%
Q3 2022$37,000
+76.2%
25,728
+125.0%
0.00%
Q2 2022$21,000
-68.2%
11,436
-53.8%
0.00%
-100.0%
Q1 2022$66,000
-32.7%
24,755
+9.3%
0.00%
-50.0%
Q4 2021$98,000
+81.5%
22,658
+111.4%
0.00%
+100.0%
Q3 2021$54,000
-69.7%
10,720
-61.9%
0.00%
-80.0%
Q2 2021$178,000
+102.3%
28,103
+147.4%
0.01%
+400.0%
Q1 2021$88,000
+252.0%
11,361
+197.1%
0.00%0.0%
Q4 2020$25,000
-90.2%
3,824
-90.0%
0.00%
-66.7%
Q3 2020$255,000
+94.7%
38,414
+143.8%
0.00%
-40.0%
Q2 2020$131,000
+309.4%
15,758
+308.7%
0.01%
+66.7%
Q4 2019$32,000
+166.7%
3,856
+133.1%
0.00%
+200.0%
Q3 2019$12,000
+20.0%
1,654
+89.2%
0.00%0.0%
Q2 2019$10,000
+900.0%
874
+2397.1%
0.00%
Q2 2018$1,000
-98.1%
35
-98.1%
0.00%
-100.0%
Q1 2018$52,000
+85.7%
1,818
+20.6%
0.00%
+100.0%
Q3 2017$28,000
+460.0%
1,508
+421.8%
0.00%
Q1 2017$5,000
+150.0%
289
+183.3%
0.00%
Q3 2016$2,000
+100.0%
102
-26.1%
0.00%
Q2 2016$1,000
-88.9%
138
-80.0%
0.00%
-100.0%
Q1 2016$9,000
-64.0%
690
-43.4%
0.00%
-75.0%
Q4 2015$25,0001,2190.00%
Other shareholders
CYTOMX THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
BVF INC/IL 5,576,471$36,526,0001.44%
Altium Capital Management LP 273,703$1,793,0000.67%
Jackson Creek Investment Advisors LLC 80,367$526,0000.21%
HARBOURVEST PARTNERS LLC 79,193$519,0000.20%
XTX MARKETS LLC 14,169$93,0000.19%
Perceptive Advisors 2,577,043$16,880,0000.18%
RTW INVESTMENTS, LP 1,527,352$10,004,0000.17%
Exane Asset Management 30,568$200,220,0000.14%
Virtus ETF Advisers LLC 37,343$245,0000.10%
Congress Park Capital LLC 25,807$169,0000.10%
View complete list of CYTOMX THERAPEUTICS INC shareholders